JOURNAL OF BUON, vol.25, no.1, pp.159-167, 2020 (SCI-Expanded)
Article / Article
JOURNAL OF BUON
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
EGFR, MUC1, PD-L1, triple negative breast cancer, prognosis, TUMOR-INFILTRATING LYMPHOCYTES, CLINICAL-FEATURES, ONCOPROTEIN, ACTIVATION, MUCINS, CARCINOMA, SURVIVAL
Çukurova University Affiliated:
Purpose: Twenty percent of the breast cancers are triple negative (TNBC). Despite the impressive progression in the biology of this subgroup, data is limited as compared to hormone and/or HER2 positive cases. Thus, the aim of this study was to detect the expression levels and to identify the prognostic values of MUC1, EGFR and PD-L1 in TNBC.